Accendra Health Inc Dossier
Qualitative Analysis
Business overview
Accendra Health Inc. (NYSE: ACH), formerly known as Owens & Minor, Inc., is a leading nationwide provider of products, technology, and services supporting healthcare beyond the hospital setting. Following the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity on December 31, 2025, the company rebranded as Accendra Health to operate as a pure-play home-based care business. The company delivers critical in-home care solutions through its two primary go-to-market brands, Apria and Byram Healthcare. Its comprehensive portfolio focuses on chronic, complex, and acute health conditions, offering essentials across diabetes management, home respiratory therapy, obstructive sleep apnea treatment, wound care, urology, and ostomy supplies.
Research as of 24 Jul 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Repositioning the company as a pure-play home-based care organization following the divestiture of its Products & Healthcare Services segment and the Owens & Minor brand to Platinum Equity.
Expected impact: Allows the company to focus 100% of its capital deployment, corporate strategy, and operational execution on its high-margin Apria and Byram Healthcare brands.
Doubling down on the sleep therapy business by piloting a Sleep Center of Excellence as a centralized point for PAP initiation and expanding the Sleep Journey program.
Expected impact: Aims to enhance patient capture, improve adherence rates, and increase average order value to drive top-line growth.
Executing a comprehensive balance sheet optimization transaction to exchange existing senior unsecured notes for new senior secured first-lien and second-lien notes, alongside refinancing its term loan.
Expected impact: Significantly extends debt maturities, reduces near-term refinancing risk, and aligns the capital structure with the company's pure-play home care profile.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Secures an exclusive multi-year extension for soft goods (including ostomy, urology, diabetes, and incontinence supplies), providing long-term revenue certainty and stabilizing the Byram Healthcare brand's market position.
Terms: Terms of the exclusive extension were not publicly disclosed.